Select Page

Groundbreaking Study Shows Cannabis Can Counter Alzheimer’s Disease

As the baby boom generation begins to reach age 65 and beyond, the number of people with Alzheimer’s disease is escalating rapidly. This debilitating condition causes deterioration of thinking skills and memory, leading to the inability to recognize loved ones or carry out basic tasks. It is the 6th leading cause of death in the U.S.

About 5.4 million Americans now live with Alzheimer’s disease, and that number is expected to rise to 13.8 million by 2050 if no prevention or cure is developed. Fortunately, medical research is beginning to understand the mechanisms of the disease, which is paving the way for treatments.

Among the most promising is the use of medical cannabis. In January we reported on a clinical study by Israeli researchers which showed that tetrahydrocannabinol (THC)—the main active ingredient in cannabis—caused a “significant reduction” in mental illness severity, particularly with regard to irritability, aggression/agitation, delusions and insomnia.

A new study carried out by the Salk Institute is providing insight into the way medical cannabis actually counters the degenerative effects of Alzheimer’s disease.

Read the full story at: Free Thought Project

The Potential Therapeutic Effects of THC on Alzheimer’s Disease

In a preclinical study published in the Journal of Alzheimer’s Disease it was found that very small doses of tetrahydrocannabinol (THC), a chemical found in marijuana, can slow the production of beta-amyloid proteins, thought to be a hallmark characteristic and key contributor to the progression of Alzheimer’s.

The study, published in 2014, is among others to support the effectiveness of THC in prohibiting the growth of toxic amyloid plagues.

Read the full story at: Alzheimers.net